Georgia's Online Cancer Information Center

Inclusion & Equity

Underserved and uninsured populations including racial and ethnic minorities and residents of rural areas experience an increased incidence of cancer, higher mortality rates, and later stages of diagnosis. To address this complex issue, Georgia CORE has become a leader in advancing cancer-focused health equity and created partnerships designed to reduce disparities in access to clinical trials, cancer screening, navigation and genetic risk assessment.

  • We facilitate a research network among academic and community partners in both urban and rural regions of the state. Collectively, 25 percent of the GA NCORP network’s clinical trials are provided to racial and ethnic minorities (five times the national average of less than five percent.)
  • In affiliation with the State Office of Rural Health of the Department of Community Health, Georgia CORE has granted more than $3.5 million in the last six years from the sale of Breast Cancer License Tags to 26 community and health organizations. Of the women who receive breast cancer education, screening and treatment provided by these grants, 85 percent are of racial and ethnic minorities.
  • In partnership with the Georgia Department of Public Health we have created a  genetics program for Hereditary Breast and Ovarian Cancer that includes professional education, online screening and risk assessment, genetic testing and personalized genetic services offered in 14 public health centers. Of the women who are provided genetic services, 63 percent are of racial and ethnic minorities; almost all are uninsured.

Last Updated: 6/24/2019 8:44:22 PM

About Us

Georgia CORE releases FY24 Impact Report

Get the latest from the center of Georgia's cancer fight from our FY24 Impact Report and also a message from the President.

12/18/2024

 About

Georgia CORE awards Cancer Research Fund grant to two teams

Georgia CORE has awarded two teams a Collaborative Cancer Research Seed Grant from the Georgia Cancer Research Fund.

5/10/2024